Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ICER
Pharma
More transparency, evidence needed for accelerated nods: ICER
The FDA should strengthen the evidence required for accelerated drug approvals and increase transparency surrounding those decisions, ICER says.
Kevin Dunleavy
Apr 17, 2026 11:22am
Novo, Lilly obesity meds 'highly cost-effective': ICER report
Sep 9, 2025 10:30am
Leerink uses broad model to weigh drugs' cost-effectiveness
Feb 18, 2025 8:56am
ICER calls out drugmakers over 'unsupported' price hikes
Dec 12, 2024 2:24pm
Pfizer's ATTR drug again faces pricing scrutiny
Oct 21, 2024 2:55pm
Pfizer's ATTR drug needs hefty discount, says ICER draft report
Jul 18, 2024 4:37pm
